1991 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Spina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 48 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Dec 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.

Research output: Contribution to journalArticle

  • Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

    Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Dec 1 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.

    Research output: Contribution to journalArticle

  • Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

    Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.

    Research output: Contribution to journalArticle

    Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study

    Rigacci, L., Puccini, B., Broccoli, A., Dona, M., Gotti, M., Evangelista, A., Santoro, A., Bonfichi, M., Re, A., Spina, M., Botto, B., Pulsoni, A., Pagani, C., Stelitano, C., Salvi, F., Nassi, L., Mannelli, L., Kovalchuk, S., Gioia, D. & Zinzani, P. L., Jan 1 2019, (Accepted/In press) In : Annals of Hematology.

    Research output: Contribution to journalArticle

  • Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

    Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

    Research output: Contribution to journalArticle